FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

24200611000001109: Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78876701000001114 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78876801000001117 Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Is a Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has active ingredient Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has active ingredient Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Cilastatin sodium false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Imipenem monohydrate false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Imipenem monohydrate true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has basis of strength substance Imipenem true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has basis of strength substance Cilastatin true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient Cilastatin sodium true Inferred relationship Existential restriction modifier
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) 1 vial Has AMP True Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start